IMM 23.0% 33.5¢ immutep limited

i feel like giving up with this stock., page-5

  1. 2,088 Posts.
    Prima is in a strong position. A lot of holders here have to look at the LT and stop worrying about the ST so much! N-Bomb will happen when it happens - no good complaining about the time of it here.

    We have to remember there is still plenty of good news that is expected to be released before the new year and these are a few key points that I think will push PRR towards $1 and beyond by Christmas:

    * Nasdaq listing: We all know this is getting closer and closer by the day. Look how well DNDN did on it's nasdaq listing - I feel the same way about PRR.
    * Completing CVac Phase IIb trial enrolment
    * Receiving manufacturing license from EMA to allow CVac to trail in Germany: This would be massive to get CVac in the door so to speak in Europe.
    * Start of Phase III trails for CVac: All indications point to Phase III trails being positive and if this is the case the potential for PRR is huge. Phase III trails are going to be the key for CVac gaining FDA approval.

    We have to remember that PRR have as good if not better management then any other BIO company going around. Martin Rogers has done a super job since becoming CEO and Dr Neil Frazer has 100% strike rate with FDA approvals.

    The present and future are very bright for PRR.I am very happy with this announcement, we couldn't ask for much more as shareholders.

    Slats.
 
watchlist Created with Sketch. Add IMM (ASX) to my watchlist
(20min delay)
Last
33.5¢
Change
-0.100(23.0%)
Mkt cap ! $486.6M
Open High Low Value Volume
39.0¢ 40.0¢ 23.0¢ $16.23M 50.19M

Buyers (Bids)

No. Vol. Price($)
4 704297 33.0¢
 

Sellers (Offers)

Price($) Vol. No.
33.5¢ 102135 2
View Market Depth
Last trade - 16.10pm 27/06/2024 (20 minute delay) ?
IMM (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.